Advantages of intraoperative implantation of Impella 5.5 SmartAssist in the Management of Acute Post-Infarction Ventricular Septal Defect with cardiogenic shock

Advantages of intraoperative implantation of Impella 5.5 SmartAssist in the Management of Acute Post-Infarction Ventricular Septal Defect with cardiogenic shock

Abstract Background Despite advances in surgical techniques and aggressive therapy of post-infarction ventricular septal defect (VSD) with cardiogenic shock, the overall morbidity and mortality is frustratingly high. The Impella 5.5 SmartAssist (Abiomed, Danvers, MA) is a surgically implanted tempor...

Full description

Bibliographic Details
Main Authors: Jeko M. Madjarov, Michael G. Katz, Svetozar Madzharov, Shahood Fazal, Francis Robicsek
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Ventricular septal defect
Impella 5.5 SmartAssist
Acute myocardial infarction
Cardiogenic shock
Online Access:https://doi.org/10.1186/s13019-021-01513-y

Internet

https://doi.org/10.1186/s13019-021-01513-y

Similar Items